Gene Query: MRPL9

Dataset Description Geneva Score
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 25.97
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 21.53
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 18.89
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 18.47
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 17.51
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 17.08
Differentially expressed genes post knock down of lincDUSP26 16.86
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 16.26
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 16.26
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 15.47
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 15.1
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 15.1
Differential gene expression of human melanoma cells [RNA-seq] 14.12
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 14.12
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 13.38
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 13.38
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 13.18
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 13.1
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 12.76
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 12.73
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 12.6
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 11.95
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 11.95
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 11.78
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 11.78
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 11.57
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.37
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 11.0
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 11.0
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.85
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.8
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 10.72
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 10.72
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 10.65
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 10.51
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 10.24
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.1
scRNASeq analysis of cycling cardiomyocytes 9.56
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.54
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.54
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.49
Effect of from Human Umbilical Vein Endothelial Cells 9.48
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.27
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.26
NRDE2 negatively regulates nuclear exosome functions 9.23
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.06
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.88
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.88
Knockdown of ADNP in HCT116 colon cancer cells 8.76
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.67
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.64
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.64
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.4
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.4
RNAseq of HEK293 cells after Chtop knockdown 8.37
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.37
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.35
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.29
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 8.28
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 8.28
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 8.24
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.24
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.24
Global analysis of enhancer targets: Mosaic-seq 8.17
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.09
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.91
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 7.88
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.85
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.83
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 7.76
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 7.75
Regulatory network controlling tumor-promoting inflammation in human cancers 7.75
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 7.74
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.6
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.57
A549 cells and MSR-A549 cells 7.57
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.49
LNCaP treated with iBET 7.45
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.35
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.35
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 7.26
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.22
Effect of mitochondria deficiency on senescence-associated gene expression 7.19
CROP-Seq in Primary Human T Cells 7.15
Rorc disruption in human FG pancreatic cancer cells 7.13
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.11
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.96
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.95
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 6.93
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.91
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.9
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.89
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.87
Lysine benzoylation is a novel histone mark 6.86
Lysine benzoylation is a novel histone mark [RNA-seq] 6.86
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.85
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 6.79
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.75
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.7
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.7
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.7
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.69
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.69
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.58
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 6.53
hnRNP C is a key regulator of protein synthesis in mitosis 6.48
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 6.45
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 6.45
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 6.44
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.43
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.43
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.38
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.38
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.37
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 6.32
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.32
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.3
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.3
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.27
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.27
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 6.27
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.23
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.23
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.17
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 6.1
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.06
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 6.02
Paxillin regulates genomic networks in prostate cancer [PC3] 6.01
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 6.0
Genome wide expression change by RNF168 knocking down in NEC cells 5.99
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.95
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 5.95
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.92
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 5.91
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 5.9
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 5.9
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.8
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.8
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.8
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 5.79
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 5.79
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.78
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.77
T47D RNA-seq and ChrRNA-seq data 5.77
A map of gene expression in neutrophil-like cell lines 5.77
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.76
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.72
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.71
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.69
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.68
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.59
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.56
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 5.55
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 5.54
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.52
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.52
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.52
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.52
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.5
Energy Metabolism during Anchorage-Independence 5.48
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.47
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.46
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.46
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.45
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 5.42
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 5.42
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.4
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 5.4
Pharmacologic inhibition of STAT5 in AML 5.39
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.38
Effect of FGF13 depletion on the H460 cell line 5.38
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.37
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.32
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.31
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.31
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.31
Control of prostate tumour growth by the long non-coding RNA GHSROS 5.26
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.25
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.25
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.22
TCF7L1 knockdown in pancreatic cancer 5.17
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.16
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.15
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.15
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 5.15
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.15
RNA-seq in transgenic cells 5.14
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.13
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.13
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.12
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 5.11
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.11
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.05
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.04
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 5.01
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.0
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.98
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.97
Co-regulation of splicing by Rbfox1 and hnRNP M 4.97
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.94
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.93
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 4.9
Gene expression changes caused by KRAS in MCF-10A 4.87
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.87
Unique features and clinical importance of acute alloreactive immune responses 4.83
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 4.81
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.81
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.8
Gene expression profile in breast cancer cell lines using RNA sequencing 4.78
The comparison of high-throughput single-cell RNA-seq methods 4.77
RNA-seq of YB5 cells treated with Proscillaridin A 4.75
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.72
RNA-seq of shEZH2 cells 4.71
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.69
TT-Seq captures the human transient transcriptome 4.67
Identification of HOXB13 target genes responsive to BET inhibitors 4.65
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 4.64
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.63
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.6
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.6
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.6
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.6
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 4.58
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.56
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.54
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.54
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.53
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.53
Transcriptome analysis upon C6orf203 silencing 4.52
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.52
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.49
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.47
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.46
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.46
PRDM1 inhibits proliferation of human colon cancer organoids 4.42
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.38
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.38
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.37
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 4.35
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.32
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.32
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.28
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.27
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.24
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.24
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.2
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.19
Gene expression changes after LOC550643 silencing 4.18
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.14
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.14
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.13
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.12
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 4.11
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.05
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.03
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.01
Discovering human diabetes-risk gene function with genetics and physiological assays 4.0
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.99
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.98
Gene expression profiling of leukemia cells following asparagine depletion 3.97
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.96
m6A-dependent regulation of messenger RNA stability 3.94
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.94
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.92
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.92
miRNAs affected by antagomiR-17 treatment 3.9
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.86
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.84
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.83
RNA-seq analysis of differentiating human erythroblasts 3.82
Ribosome profiling upon inhibition of eIF4A 3.79
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.74
Iron response of HepG2 cells 3.74
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.73
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.71
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.68
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.66
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.63
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.62
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.61
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.55
Biological effect of chronic mistranslation in mammalian cells 3.54
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.48
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.46
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 3.44
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.42
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.4
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.38
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.34
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.34
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.33
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.33
O-glcnAc reprograms cellular energetics 3.3
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.3
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.3
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.25
Transcriptome sequencing of K-562 cells 3.24
Cajal bodies are linked to genome conformation [RNA-Seq] 3.23
Cajal bodies are linked to genome conformation 3.23
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.23
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.22
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.22
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.22
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.2
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.16
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.16
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.13
IMP3 regulated gene expression in breast cancer cells 3.11
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.06
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.05
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.04
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.02
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.02
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.98
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.98
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.97
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.96
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.95
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.92
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.91
Studying the selectivity of a small molecule Synucleozid on transcriptome 2.91
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.9
Gene expression in GBM with Cav3.2 inhibition 2.89
The bromodomain protein BRD4 regulates splicing during heat shock 2.87
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.86
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.86
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.83
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.82
Transcriptomic analyssis following EHMT1/2 inhibition 2.81
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.8
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.8
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.79
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.79
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.74
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.74
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.73
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.67
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.67
The cohesin complex prevents Myc-induced replication stress 2.66
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.65
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.65
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.64
Human Treg NaCl stimulation 2.62
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.62
RNA-seq analysis upon ARID1B overexpression 2.56
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.51
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.49
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.49
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.48
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.45
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.44
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.43
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.38
N6-methyladenine DNA Modification in Glioblastoma 2.38
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.36
RNA editing in nascent RNA affects pre-mRNA splicing 2.36
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.34
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.34
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.29
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.26
Functional significance of the HIV-1 Tat signature amino acid residues 2.26
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.23
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.18
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.15
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.15
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.15
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.12
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 2.1
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.04
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.02
Role of FGFR1 in neuronal devlopment 2.0
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.99
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.96
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.95
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.92
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.91
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.89
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.84
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.82
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.77
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.77
mRNA expression in human DAOY cells 1.72
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.72
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.7
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.68
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.68
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.66
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.66
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.59
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.56
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.56
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 1.56
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 1.56
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.55
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.55
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.55
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.54
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.54
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.53
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.39
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.39
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.39
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.37
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.37
Loss of CREBBP results in gene expression repression in lymphoma cells 1.34
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.34
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.34
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.33
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.32
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.32
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.3
Comparative Analysis of Cas9 Activators Across Multiple Species 1.29
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 1.27
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.25
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.23
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.22
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.2
RNA-seq data 1.14
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.14
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.13
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.12
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.12
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.09
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.06
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.05
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.03
Interaction between mitoNEET and NAF-1 in cancer cells 0.96
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.95
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.93
RNAseq of cell lines with knocked in ESR1 mutations 0.93
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.92
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.91
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.91
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.88
RNA seq with AML (NB4) cells upon FTO inhibition 0.85
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.84
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.83
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.82
Expression profiling of MCF-7 cells with treatment of TCDD 0.8
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.8
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.79
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.78
KSDM1b Role in Ewing Sarcoma 0.77
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.77
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.75
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.72
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.71
Hepatic transcriptome of pediatric hepatoblastoma. 0.67
Measure transcript integrity using RNA-seq data 0.62
Impact on erythroid progenitor type on erythroid differntiation 0.61
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.6
Genome-wide analysis of the Integrator complex (HTS) 0.58
Genome-wide analysis of the Integrator complex 0.58
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.56
Human Treg IL-12 stimulation 0.55
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.55
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.53
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.5
SF3B1 Degron knockdown RNA-seq 0.49
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.46
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.44
Dermal endothelial cells of type 2 diabetic patients 0.44
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.44
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.43
High-resolution comparative analysis of great ape genomes 0.4
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.39
siRNA-mediated knockdown 0.37
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.36
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.36
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.35
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.35
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.29
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.29
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.26
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.23
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.22
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.21
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.2
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.19
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.19
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.19
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.19
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.19
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.17
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.15
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.14
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.13
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.13
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.1
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.05
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.05
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.04
Function and hormonal regulation of GATA3 in human first trimester placentation 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation